retatrutide phase 2 trial type 2 diabetes weight loss Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released results demonstrating 25% in half of people with #obesity. This amount of weight loss has not been accomplished Retatrutide vs Tirzepatide (2026): Differences

Avoiding the mistakes that undermine your protocol is equally important

Conversely, the first line treatment for IIH, acetazolamide, has little to no effect on weight loss ( Table 2 ) (16)

Proanthocyanidins in cranberries can prevent E

The emotional labor once required to earn a transformation can now be bypassed with a single prescription

Pictured from left: Vivian Cheng, PA-C, Dr

The House-version of the annual defense policy bill, which passed out of the chamber this summer, includes a provision that would require the defense secretary to develop a strategy to align the Pentagons obesity-related programs with the classification of obesity as a medically accepted disease